The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review

INTRODUCTION: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has been widely used and studied for the treatment of motor fluctuations in levodopa-responsive patients with advanced Parkinson’s disease (PD) when other treatments have not given satisfactory results. Red...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonini, Angelo, Odin, Per, Pahwa, Rajesh, Aldred, Jason, Alobaidi, Ali, Jalundhwala, Yash J., Kukreja, Pavnit, Bergmann, Lars, Inguva, Sushmitha, Bao, Yanjun, Chaudhuri, K. Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189983/
https://www.ncbi.nlm.nih.gov/pubmed/34018146
http://dx.doi.org/10.1007/s12325-021-01747-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189983/
https://www.ncbi.nlm.nih.gov/pubmed/34018146
http://dx.doi.org/10.1007/s12325-021-01747-1

Ejemplares similares